Molecular Classification
Enzyme, Metabolic enzyme/protease, GMC oxidoreductase family (glucose-methanol-choline oxidoreductases), Flavin/deazaflavin oxidoreductase (FDOR), Molybdopterin oxidoreductase (DMSO family), Oxygenase, Peroxidase, Dehydrogenase, Reductase, etc., Catalase (heme and non-heme), Classified by EC number: EC 1.x.x.x
Other Names
Oxidoreductase, Redox enzyme, Dehydrogenase (when O₂ is not acceptor), Reductase, Oxidase (when O₂ is acceptor), EC 1 enzymes (Enzyme Commission class), Specific names by substrate (e.g., Alcohol dehydrogenase, Glucose oxidase, Catalase, Monoamine oxidase, Peroxidase)
Disease Roles
Infection (roles in pathogen metabolism and antibiotic resistance)Inflammation (redox state regulation)Other: Oxidative stress-associated conditions, biotechnology enzyme applications, metabolic disorders (when mutated in bacteria)

Bacterial oxidoreductase enzyme Overview

Bacterial oxidoreductase enzymes are a diverse group of enzymes (classified in EC 1) that catalyze redox reactions—electron transfer between molecules—essential for cellular metabolism, energy production, and detoxification in bacteria. They comprise various families (dehydrogenases, reductases, oxidases, peroxidases, oxygenases, catalases) and show wide structural and mechanistic diversity, employing cofactors such as NAD/NADP, FMN, FAD, Heme, or metal ions. They are widespread in bacterial species, with some subclasses unique to bacteria or archaea (e.g., certain Mn-catalases and DMSO/molybdopterin oxidoreductases). Their functional roles include core metabolism, adaptation to stress, and, in some bacteria, alternative energy production. As therapeutic targets, they are recognized for roles in infection (bacterial viability and antibiotic resistance), and as industrial biocatalysts, they are valued for oxidation, reduction, and detoxification processes under extreme conditions. The term is an umbrella for hundreds of distinct enzymes, each with specialized substrates, cofactors, and disease or biotechnology importance.

Mechanism of Action

Inhibition of electron transfer/metabolic pathway activity; Generation of reactive oxygen species (ROS); Interference with substrate binding or cofactor utilization (NAD/NADP, FMN, FAD, Heme, Iron-sulfur cluster); Modification or destruction of bacterial energy metabolism

Biological Functions

Electron transfer (redox reactions)
Cellular respiration
Metabolism of carbohydrates, amino acids, lipids, xenobiotics
Detoxification (e.g., degradation of reactive oxygen species)
Energy production (particularly in bacteria lacking cytochrome bc complexes)
Biosynthesis of cofactors
Biotechnological catalysis

Disease Associations

Infection (roles in pathogen metabolism and antibiotic resistance)
Inflammation (redox state regulation)
Other: Oxidative stress-associated conditions, biotechnology enzyme applications, metabolic disorders (when mutated in bacteria)

Safety Considerations

  • Off-target toxicity: Inhibitors may affect human homologs or gut microbiota oxidoreductases
  • Redox imbalance: Unintended modulation may promote oxidative stress—the therapeutic window is often tight.
  • Resistance development in bacteria: Especially with antibiotics targeting redox enzymes.
  • Biotechnological challenges: Stability, activity under industrial conditions, supply chain (noted for extremophilic oxidoreductases)

Interacting Drugs

Antibiotics (modulating oxidoreductase enzymes in pathogens)
Redox-active inhibitors (targeting bacterial dehydrogenases, oxidases, oxygenases, etc.)
Specific drugs vary by enzyme type (e.g., isoniazid for bacterial catalase-peroxidase, antibacterial peroxidase inhibitors, etc.), but no universal drug set exists for the whole class

Associated Biomarkers

Biomarker
Enzyme activity assays for specific oxidoreductases (e.g., NADH dehydrogenase activity)
Metabolic profiling for redox balance or oxidative stress
Presence of oxidoreductase gene/protein in pathogens (diagnostic PCR or proteomics)
Specific biomarkers exist for individual enzymes, not for the broad class.